Re­silience forges JV with MD An­der­son, ready­ing new cell ther­a­pies for can­cer

The Uni­ver­si­ty of Texas MD An­der­son Can­cer Cen­ter and con­tract bi­o­log­ic man­u­fac­tur­er Re­silience are crack­ing open a new part­ner­ship, seek­ing to ac­cel­er­ate the de­vel­op­ment and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.